Correlation Between Dupont De and Forward Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Forward Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Forward Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Forward Pharma A, you can compare the effects of market volatilities on Dupont De and Forward Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Forward Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Forward Pharma.

Diversification Opportunities for Dupont De and Forward Pharma

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Dupont and Forward is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Forward Pharma A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forward Pharma A and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Forward Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forward Pharma A has no effect on the direction of Dupont De i.e., Dupont De and Forward Pharma go up and down completely randomly.

Pair Corralation between Dupont De and Forward Pharma

Allowing for the 90-day total investment horizon Dupont De is expected to generate 296.01 times less return on investment than Forward Pharma. But when comparing it to its historical volatility, Dupont De Nemours is 86.29 times less risky than Forward Pharma. It trades about 0.04 of its potential returns per unit of risk. Forward Pharma A is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  297.00  in Forward Pharma A on September 2, 2024 and sell it today you would lose (41.00) from holding Forward Pharma A or give up 13.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy11.09%
ValuesDaily Returns

Dupont De Nemours  vs.  Forward Pharma A

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Forward Pharma A 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Forward Pharma A has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Forward Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Dupont De and Forward Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Forward Pharma

The main advantage of trading using opposite Dupont De and Forward Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Forward Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forward Pharma will offset losses from the drop in Forward Pharma's long position.
The idea behind Dupont De Nemours and Forward Pharma A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bonds Directory
Find actively traded corporate debentures issued by US companies